Craneware R&D per Employee
Delisted·Jun 19, 2026
R&D Spending per Employee of Craneware (CRW.L) as of Aug 10, 2026.
Get this data via API
Financial Data API
R&D per Employee
0.00USD
Last updated:
R&D Spending per Employee of Craneware is 2026 0.00 USD. R&D Spending per Employee of Craneware was 2025 0.00 USD. It decreases by % lower compared to the previous year.
Access this data via the Eulerpool API
Craneware Stock analysis
What does Craneware do? Craneware PLC is a publicly traded company based in Edinburgh, Scotland, that specializes in the development and marketing of software solutions for the healthcare industry. The company was founded in 1999 and has been listed on the London Stock Exchange since 2007.
The business model of Craneware is based on the development and marketing of software solutions for the healthcare industry that help customers optimize their financial and performance processes. Craneware focuses particularly on the area of Revenue Cycle Management (RCM), which involves the management of hospital billing and payment processes.
Craneware's software solutions are used in various areas, including billing, pricing, contract management, compliance, and analytics. The products are modular and can be individually configured according to the customer's needs.
One example of a product is the Revenue Integrity Management System (RIMS), which allows for comprehensive analysis of patient billing and ensures that hospitals maximize their revenue while complying with regulations.
Other products include Reference Plus, which helps customers determine and stay competitive with pricing for medical services, and the Online Analytics Suite, which specializes in data analysis and reporting.
Craneware is divided into different divisions, including North America, International, and UK & EMEA. North America is the largest market for the company, accounting for approximately 90% of its revenue.
In North America, Craneware has a strong presence and works closely with many large hospitals and healthcare organizations. The company's focus on RCM solutions has received significant attention, and many customers appreciate the efficiency and effectiveness of the software solutions.
In the International division, Craneware focuses on expanding its presence in Europe, Asia, Africa, and the Middle East. The company has already gained many partners in these regions and is working to further expand its market share.
In the UK & EMEA division, Craneware primarily serves NHS hospitals (National Health Service) and offers a wide range of RCM solutions to its customers.
Craneware was founded in 1999 by Edinburgh University graduate Gordon Craig. The company's headquarters were established in Edinburgh and quickly became a major employer in the city.
In 2007, Craneware was listed on the London Stock Exchange and has since been a publicly traded company. In 2015, the company was included in the FTSE AIM 100 Index.
In recent years, Craneware has experienced strong growth and expanded its market presence to different countries. The company plans to continue investing in research and development and focusing on innovation to provide its customers with the best RCM solutions in the future. Craneware is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Craneware stock
On Eulerpool you can find the complete historical development of R&D Spending per Employee Craneware since 2006 – with annual values, charts, and detailed analysis.
R&D per employee shows the research and development investment allocated per employee. Higher values indicate innovation-focused companies.
R&D Spending per Employee's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track R&D Spending per Employee's Craneware historically and in real time.
Access this data via the Eulerpool API
Workforce — Craneware
All Key Metrics — Craneware
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth